- Home
- PCRX vs SPHR Comparison
PCRX vs SPHR Comparison
Compare PCRX & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SPHR
- Stock Information
- Founded
- PCRX 2006
- SPHR 2020
- Country
- PCRX United States
- SPHR United States
- Employees
- PCRX N/A
- SPHR N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SPHR Services-Misc. Amusement & Recreation
- Sector
- PCRX Health Care
- SPHR Consumer Discretionary
- Exchange
- PCRX Nasdaq
- SPHR Nasdaq
- Market Cap
- PCRX 1.2B
- SPHR 1.3B
- IPO Year
- PCRX 2011
- SPHR N/A
- Fundamental
- Price
- PCRX $24.10
- SPHR $38.56
- Analyst Decision
- PCRX Buy
- SPHR Buy
- Analyst Count
- PCRX 9
- SPHR 10
- Target Price
- PCRX $29.89
- SPHR $46.70
- AVG Volume (30 Days)
- PCRX 546.7K
- SPHR 527.8K
- Earning Date
- PCRX 07-29-2025
- SPHR 08-13-2025
- Dividend Yield
- PCRX N/A
- SPHR N/A
- EPS Growth
- PCRX N/A
- SPHR N/A
- EPS
- PCRX N/A
- SPHR N/A
- Revenue
- PCRX $702,772,000.00
- SPHR $1,031,650,000.00
- Revenue This Year
- PCRX $7.54
- SPHR $9.19
- Revenue Next Year
- PCRX $10.78
- SPHR $6.40
- P/E Ratio
- PCRX N/A
- SPHR N/A
- Revenue Growth
- PCRX 3.08
- SPHR 16.89
- 52 Week Low
- PCRX $11.16
- SPHR $23.89
- 52 Week High
- PCRX $29.61
- SPHR $50.88
- Technical
- Relative Strength Index (RSI)
- PCRX 36.99
- SPHR 57.23
- Support Level
- PCRX $23.99
- SPHR $37.94
- Resistance Level
- PCRX $24.90
- SPHR $40.06
- Average True Range (ATR)
- PCRX 0.88
- SPHR 1.18
- MACD
- PCRX -0.21
- SPHR -0.26
- Stochastic Oscillator
- PCRX 11.61
- SPHR 50.56
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.